Compounds of formula (I), wherein the substituents are as defined in claim 1, and agrochemically acceptable salts and enantiomers thereof, can be used as insecticides.

##STR00001##

The present disclosure relates to a composition having a structure that includes ##STR00001##
where R.sub.1 includes at least one of hydrogen, carbon, and/or fluorine, and includes a covalent bond. In some embodiments of the present disclosure, R.sub.1 may include at least one of hydrogen, fluorine, a carboxyl group, a hydroxyl group, an alkoxy group, and/or a hydrocarbon chain. In some embodiments of the present disclosure, the composition may be derived from at least one of ##STR00002##
In some embodiments of the present disclosure, at least a portion of the composition may be bioderived.

The present disclosure relates to a composition having a structure that includes ##STR00001##
where R.sub.1 includes at least one of hydrogen, carbon, and/or fluorine, and includes a covalent bond. In some embodiments of the present disclosure, R.sub.1 may include at least one of hydrogen, fluorine, a carboxyl group, a hydroxyl group, an alkoxy group, and/or a hydrocarbon chain. In some embodiments of the present disclosure, the composition may be derived from at least one of ##STR00002##
In some embodiments of the present disclosure, at least a portion of the composition may be bioderived.

The present disclosure is related to an organic EL element including a capping layer that contains a compound represented by formula (A-1). In the formula, A and X are monovalent groups represented by formula (B-1) having 1 binding site among R.sub.1 to R.sub.6. Z represents a monovalent group represented by formula (B-1) having 1 binding site among R.sub.1 to R.sub.6, an aromatic hydrocarbon group, an aromatic heterocyclic group or a fused polycyclic aromatic group. Ar is a single bond or a divalent group of an aromatic hydrocarbon group, an aromatic heterocyclic group, or a fused polycyclic aromatic group. R.sub.1 to R.sub.6 each represent a linking group as a binding site, a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a cyano group, a nitro group, a linear or branched alkyl group, a cycloalkyl group, an alkenyl group, an alkyloxy group, a cycloalkyloxy group, an aromatic hydrocarbon group, an aromatic heterocyclic group, a fused polycyclic aromatic group, or an aryloxy group. Q represents a nitrogen atom, an oxygen atom, or a sulfur atom. ##STR00001##

Provided are imaging agents comprising a compound of Formula I, or a pharmaceutically acceptable salt thereof, and methods of their use.

##STR00001##

The present disclosure relates to a plurality of host materials comprising a first host material including a compound represented by formula 1 and a second host material including a compound represented by formula 2, and an organic electroluminescent device comprising the same. In addition, the present disclosure relates to an organic electroluminescent compound, and an organic electroluminescent device comprising the same. By comprising the organic electroluminescent compound and/or a specific combination of compounds according to the present disclosure as host materials, an organic electroluminescent device having high luminous efficiency and long lifespan property can be provided.

The present disclosure relates to a plurality of host materials comprising a first host material including a compound represented by formula 1 and a second host material including a compound represented by formula 2, and an organic electroluminescent device comprising the same. In addition, the present disclosure relates to an organic electroluminescent compound, and an organic electroluminescent device comprising the same. By comprising the organic electroluminescent compound and/or a specific combination of compounds according to the present disclosure as host materials, an organic electroluminescent device having high luminous efficiency and long lifespan property can be provided.

The present invention provides an SSAO inhibitor and an application thereof in preparing a drug for treating a disease related to SSAO. In particular, the present invention provides a compound shown in formula (IV) and a pharmaceutically acceptable salt thereof. ##STR00001##

The present invention provides an SSAO inhibitor and an application thereof in preparing a drug for treating a disease related to SSAO. In particular, the present invention provides a compound shown in formula (IV) and a pharmaceutically acceptable salt thereof. ##STR00001##

Disclosed are compounds of Formula (I′), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections. ##STR00001##